To evaluate the potential of delayed-enhancement MRI using gadofosveset as a prognostic tool for aneurysm rupture, we performed a longitudinal study of ApoE−/− mice with gadofosveset imaging after 1 week of AngII infusion and with fatal aneurysm rupture as the endpoint (study 1, n = 18). This evidence concerns the gene AGT and aneurysm.